Literature DB >> 11973653

Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53.

Toshiki Mori1, Yoshio Anazawa, Megumi Iiizumi, Seisuke Fukuda, Yusuke Nakamura, Hirofumi Arakawa.   

Abstract

Interferon regulatory factors (IRFs) regulate transcription of interferon genes through DNA sequence-specific binding to these targets. Using a differential display method for examining gene expression in p53-defective cells infected with adenovirus containing wild-type p53, we found that expression of interferon regulatory factor 5 (IRF-5) mRNA was increased in the presence of exogenous p53. An electrophoretic mobility-shift assay showed that a potential p53 binding site (p53BS) detected in exon 2 of the IRF-5 gene could in fact bind to p53 protein. Moreover, a heterologous reporter assay revealed that the p53BS possessed p53-dependent transcriptional activity. Expression of IRF-5 was induced in p53+/+ cells (MCF7 and NHDF), but not inp53-/- cells (H1299) when DNA was damaged by gamma-irradiation, UV-radiation, or adriamycin treatment in a wild-type p53-dependent manner. These results suggest that IRF-5 is a novel p53-target, and that it might mediate the p53-dependent immune response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11973653     DOI: 10.1038/sj.onc.1205459

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  63 in total

Review 1.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

Review 2.  The IRF family, revisited.

Authors:  A Paun; P M Pitha
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

3.  Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes.

Authors:  Yong Zhao; Dongsheng Xu; Yanjun Jiang; Luwen Zhang
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

4.  A functional SNP in ITIH3 is associated with susceptibility to myocardial infarction.

Authors:  Yusuke Ebana; Kouichi Ozaki; Katsumi Inoue; Hiroshi Sato; Aritoshi Iida; Htay Lwin; Susumu Saito; Hiroya Mizuno; Atsushi Takahashi; Takahiro Nakamura; Yoshinari Miyamoto; Shiro Ikegawa; Keita Odashiro; Masakiyo Nobuyoshi; Naoyuki Kamatani; Masatsugu Hori; Mitsuaki Isobe; Yusuke Nakamura; Toshihiro Tanaka
Journal:  J Hum Genet       Date:  2007-01-09       Impact factor: 3.172

5.  Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.

Authors:  Elangovan Thavathiru; John H Ludes-Meyers; Michael C MacLeod; C Marcelo Aldaz
Journal:  Mol Carcinog       Date:  2005-11       Impact factor: 4.784

Review 6.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

7.  IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Authors:  Christophe Richez; Kei Yasuda; Ramon G Bonegio; Amanda A Watkins; Tamar Aprahamian; Patricia Busto; Rocco J Richards; Chih Long Liu; Regina Cheung; Paul J Utz; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

Review 8.  Long story short: p53 mediates innate immunity.

Authors:  Jessica Miciak; Fred Bunz
Journal:  Biochim Biophys Acta       Date:  2016-03-04

9.  Functional analysis of a dominant negative mutation of interferon regulatory factor 5.

Authors:  Long Yang; Tiejun Zhao; Xiaoliu Shi; Peyman Nakhaei; Yunling Wang; Qiang Sun; John Hiscott; Rongtuan Lin
Journal:  PLoS One       Date:  2009-05-11       Impact factor: 3.240

10.  Development of monoclonal antibodies against human IRF-5 and their use in identifying the binding of IRF-5 to nuclear import proteins karyopherin-alpha1 and -beta1.

Authors:  Soo-In Yeon; Ju Ho Youn; Mi Hwa Lim; Hye Ja Lee; Young Mok Kim; Ji Eun Choi; Jae Myun Lee; Jeon-Soo Shin
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.